Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :
| 1 Year | 3 Year | 5 Year | 9 Year | |
| CAGR(%) | 63.43 | 21.39 | 25.69 | N/A |
| Average Rolling Returns(%) | 27.84 | 23.90 | 23.01 | N/A |
The Current NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is ₹32.43.
You should look for a fund with better more consistent performance track record. Funds returns are more likely to be different than its benchmark NIFTY 50 - TRI returns, as Funds portfolio is significantly different.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan fund’s expense ratio is 1.04%
The process for redemption is
The AUM of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is currently ₹3,772 Crores.
The Top three stocks are Sun Pharma Inds., Dr. Reddys Lab and Divis Lab and account for 29% of its portfolio. Top 5 and 10 stocks of fund account for 42% and 62% of fund’s portfolio respectively.
Top three sectors of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan fund are Healthcare, BFSI and Chemicals accounting for 95% of the total portfolio.
Funds Portfolio Quality is Somewhat Good. It has a large proportion of Green and Orange Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.
The category of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.
Dharmesh Kakkad manages the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan Fund.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan current PE ratio is 49.64 and PB ratio is 6.22
The asset allocation of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is Stocks : 98.69%, Debt : 1.30% and Gold : 0%
The minimum SIP amount for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is ₹100.00 and minimum lumpsum is ₹5000.00
The exit load for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan is 1% on or before 15 days, Nil after 15 days
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
